AI assistant
FRONTIER IP GROUP PLC — Board/Management Information 2019
Sep 10, 2019
7653_rns_2019-09-10_a900c4d5-7b53-4702-98ae-35bb9d89baa4.html
Board/Management Information
Open in viewerOpens in your device viewer
National Storage Mechanism | Additional information
You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.
RNS Number : 7126L
Frontier IP Group plc
10 September 2019
10 September 2019
Frontier IP Group Plc
("Frontier IP" or the "Group")
Appointment of Broker
Frontier IP, a specialist in commercialising university intellectual property, announces the appointment of Nplus1 Singer Advisory LLP ("N+1 Singer") as the Group's sole broker with immediate effect.
Allenby Capital Limited remains the Group's Nominated Adviser.
ENQUIRIES
| Frontier IP Group Plc | T: 020 7332 2338 |
| Neil Crabb, Chief Executive | |
| Andrew Johnson, Communications & Investor Relations | M: 07464 546 025 |
| www.frontierip.co.uk | |
| Allenby Capital Limited (Nominated Adviser) | T: 0203 328 5656 |
| Nick Athanas / Nicholas Chambers | |
| N+1 Singer (Broker) | T: 0207 496 3000 |
| Harry Gooden / George Tzimas |
ABOUT FRONTIER IP
Frontier IP unites science and commerce by identifying strong intellectual property and accelerating its development through a range of commercialisation services. A critical part of the Group's work is involving relevant industry partners at an early stage of development to ensure technology meets real world demands and needs.
The Group looks to build and grow a portfolio of equity stakes and licence income by taking an active involvement in spin-out companies, including support for fund raising and collaboration with relevant industry partners at an early stage of development.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
END
APPEASNNEEFNEFF